From curse to cure: Hiv for gene therapy?

Nature Biotechnology

Volumn 14, Issue 8, 1996, Pages 943-

  Emerman, Michael ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE THERAPY; HEMATOPOIETIC CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; NOTE; PRIORITY JOURNAL; RETROVIRUS; VIRUS GENOME;

GENE THERAPY; GENETIC VECTORS; HIV; HUMANS;

EID: 0029821311     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0896-943     Document Type: Article

References (11)

1. Lewis, R, Hensel, M., and Emerman, M. 1992. EMBO J. 11:3053–3058.
2. Bukrinsky, M.I. et al. 1992. Proc. Natl. Acad. Sci. USA 89:6580–6884.
3. Naldini, L. et al. 1996. Science 272:263–267.
4. Tang, S., Patterson, B., and Levy, J.A. 1995. J. Virol. 69:5659–5665.
5. Zack, J.A. et al. 1990. Cell 61:213–222.
6. Akkina, R.K. et al. 1996. J. Virol. 70:2581–2585.
7. Rolls, M.M., Webster, P., Balba, N.H., and Rose, J.K. 1994. Cell 79:497–506.
8. Yu, H., Rabson, A.B., Kaul, M., Ron, Y„ and Dougherty, J.R. 1996. J. Virol. 70:4530–4537.
9. Russell, D.W. and Miller, A.D. 1996. J Virol. 70:217–222.
10. Bieniasz, P.D., Weiss, R.A., and McClure, M.O.1995. J. Virol. 69:7295–7299.
11. Stevenson, M. Trends Cell Biol. 1995.6:9–15.